ABSTRACT
Glioma that is recurring or progressing after standard therapy.
Breadcrumbs Section. Click here to navigate to respective pages.
Chapter
Chapter
DOI link for Temozolomide (single-agent)
Temozolomide (single-agent)
Glioma that is recurring or progressing after standard therapy.
Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG© 2024 Informa UK Limited